About: In vitro and ex vivo systems at the forefront of infection modeling and drug discovery

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: In vitro and ex vivo systems at the forefront of infection modeling and drug discovery Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	In vitro and ex vivo systems at the forefront of infection modeling and drug discovery
Creator	Wang, Mian Mi, Gujie Shi, Di Webster, Thomas
source	Elsevier; Medline; PMC
abstract	Abstract Bacterial infections and antibiotic resistant bacteria have become a growing problem over the past decade. As a result, the Centers for Disease Control predict more deaths resulting from microorganisms than all cancers combined by 2050. Currently, many traditional models used to study bacterial infections fail to precisely replicate the in vivo bacterial environment. These models often fail to incorporate fluid flow, bio-mechanical cues, intercellular interactions, host-bacteria interactions, and even the simple inclusion of relevant physiological proteins in culture media. As a result of these inadequate models, there is often a poor correlation between in vitro and in vivo assays, limiting therapeutic potential. Thus, the urgency to establish in vitro and ex vivo systems to investigate the mechanisms underlying bacterial infections and to discover new-age therapeutics against bacterial infections is dire. In this review, we present an update of current in vitro and ex vivo models that are comprehensively changing the landscape of traditional microbiology assays. Further, we provide a comparative analysis of previous research on various established organ-disease models. Lastly, we provide insight on future techniques that may more accurately test new formulations to meet the growing demand of antibiotic resistant bacterial infections.
has issue date	2019-04-30(xsd:dateTime)
bibo:doi	10.1016/j.biomaterials.2018.10.030
bibo:pmid	30384974
has license	els-covid
sha1sum (hex)	0ac0e2eea2bcd4b5015bcfe9dfb62bae24cfba67
schema:url	https://doi.org/10.1016/j.biomaterials.2018.10.030
resource representing a document's title	In vitro and ex vivo systems at the forefront of infection modeling and drug discovery
has PubMed Central identifier	PMC7172914
has PubMed identifier	30384974
schema:publication	Biomaterials
resource representing a document's body	covid:0ac0e2eea2bcd4b5015bcfe9dfb62bae24cfba67#body_text
is schema:about of	named entity 'fluid flow' named entity 'antibiotic' named entity 'result' named entity 'vivo' named entity 'physiological' named entity 'study' named entity 'accurately' named entity 'result' named entity 'models' named entity 'fail' named entity 'environment' named entity 'PROBLEM' named entity 'UPDATE' named entity 'S T' named entity 'THERAPEUTIC' named entity 'comparative' named entity 'bacterial infections' named entity 'cues' named entity 'culture media' named entity 'growing' named entity 'Further' named entity 'resistant' named entity 'therapeutic' named entity 'microbiology' named entity 'modeling' named entity 'antibiotic resistant bacteria' named entity 'Centers for Disease Control' named entity 'bacterial infections' named entity 'bacterial infections' named entity 'microorganisms' named entity 'infection' named entity 'assays' named entity 'problem' named entity 'Disease Control' named entity 'embryoid bodies' named entity 'lipopolysaccharide' named entity 'biofilm formation' named entity 'physiological' named entity 'ZIKV' named entity 'host immune responses' named entity 'E. coli' named entity 'causal agents' named entity 'pathogenesis' named entity 'pig' named entity 'microfluidic devices' named entity 'IL-6' named entity 'bacteria' named entity 'PMNs' named entity 'Haemophilus influenza' named entity 'nanofabrication' named entity 'P. aeruginosa' named entity 'extracellular polymeric substances' named entity 'pig skin' named entity 'bacterial colonization' named entity 'Escherichia coli' named entity 'ZO-1' named entity 'Liver' named entity 'model systems' named entity 'dermis' named entity 'lung-on-a-chip' named entity 'environmental conditions' named entity 'non-destructive' named entity 'antimicrobials' named entity 'E.coli' named entity 'homeostasis' named entity 'mammalian cells' named entity 'biofilms' named entity 'Matrigel' named entity 'adipose tissue' named entity 'microbe' named entity 'inflammatory responses' named entity 'co-cultured' named entity 'ATCC' named entity 'signaling pathway' named entity 'biofilms' named entity 'catheters' named entity 'tight junction' named entity 'endothelial cells'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software